25 XP   0   0   10

Wuhan Hvsen Biotechnology Co Ltd
Buy, Hold or Sell?

Let's analyse Wuhan Hvsen Biotechnology Co Ltd together

PenkeI guess you are interested in Wuhan Hvsen Biotechnology Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Wuhan Hvsen Biotechnology Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Wuhan Hvsen Biotechnology Co Ltd

I send you an email if I find something interesting about Wuhan Hvsen Biotechnology Co Ltd.

Quick analysis of Wuhan Hvsen Biotechnology Co Ltd (30 sec.)










What can you expect buying and holding a share of Wuhan Hvsen Biotechnology Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.21
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥9.28
Expected worth in 1 year
¥7.46
How sure are you?
83.3%

+ What do you gain per year?

Total Gains per Share
¥-0.31
Return On Investment
-2.2%

For what price can you sell your share?

Current Price per Share
¥14.25
Expected price per share
¥9.64 - ¥17.44
How sure are you?
50%

1. Valuation of Wuhan Hvsen Biotechnology Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥14.25

Intrinsic Value Per Share

¥-37.49 - ¥-29.41

Total Value Per Share

¥-28.21 - ¥-20.13

2. Growth of Wuhan Hvsen Biotechnology Co Ltd (5 min.)




Is Wuhan Hvsen Biotechnology Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$212.8m$223.5m-$10.6m-5.0%

How much money is Wuhan Hvsen Biotechnology Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$7.2m$18.3m-$11m-152.1%
Net Profit Margin5.2%13.3%--

How much money comes from the company's main activities?

3. Financial Health of Wuhan Hvsen Biotechnology Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#243 / 1009

Most Revenue
#87 / 1009

Most Profit
#101 / 1009

Most Efficient
#135 / 1009

What can you expect buying and holding a share of Wuhan Hvsen Biotechnology Co Ltd? (5 min.)

Welcome investor! Wuhan Hvsen Biotechnology Co Ltd's management wants to use your money to grow the business. In return you get a share of Wuhan Hvsen Biotechnology Co Ltd.

What can you expect buying and holding a share of Wuhan Hvsen Biotechnology Co Ltd?

First you should know what it really means to hold a share of Wuhan Hvsen Biotechnology Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Wuhan Hvsen Biotechnology Co Ltd is ¥14.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Wuhan Hvsen Biotechnology Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Wuhan Hvsen Biotechnology Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.28. Based on the TTM, the Book Value Change Per Share is ¥-0.45 per quarter. Based on the YOY, the Book Value Change Per Share is ¥1.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.38 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Wuhan Hvsen Biotechnology Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.3%0.040.3%0.110.8%0.080.6%0.080.5%
Usd Book Value Change Per Share-0.06-0.4%-0.06-0.4%0.201.4%0.221.5%0.211.5%
Usd Dividend Per Share0.050.4%0.050.4%0.040.3%0.030.2%0.020.2%
Usd Total Gains Per Share-0.01-0.1%-0.01-0.1%0.241.7%0.241.7%0.241.7%
Usd Price Per Share2.82-2.82-3.93-2.45-2.04-
Price to Earnings Ratio64.27-64.27-35.64-28.80-24.00-
Price-to-Total Gains Ratio-259.62--259.62-16.63--78.80--78.80-
Price to Book Ratio2.20-2.20-2.92-1.99-1.65-
Price-to-Total Gains Ratio-259.62--259.62-16.63--78.80--78.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.967925
Number of shares508
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.03
Usd Book Value Change Per Share-0.060.22
Usd Total Gains Per Share-0.010.24
Gains per Quarter (508 shares)-5.51124.45
Gains per Year (508 shares)-22.05497.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1106-128-3252445488
2211-255-54105891986
3317-383-7615713361484
4422-511-9820917821982
5528-638-12026122272480
6634-766-14231426732978
7739-894-16436631183476
8845-1021-18641835643974
9950-1149-20847140094472
101056-1276-23052344554970

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%5.01.00.083.3%5.01.00.083.3%

Fundamentals of Wuhan Hvsen Biotechnology Co Ltd

About Wuhan Hvsen Biotechnology Co Ltd

Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin tartrate powders and raw materials; florfenicol, cefquinome sulfate, and tildipirosin injections; and florfenicol powder/WSP, tylosin tartrate soluble powder, and tywasin premix products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. was founded in 2002 and is based in Wuhan, China.

Fundamental data was last updated by Penke on 2024-04-23 09:21:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Wuhan Hvsen Biotechnology Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Wuhan Hvsen Biotechnology Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 5.2% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 5.2%. The company is making a profit. +1
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM5.2%0.0%
TTM5.2%YOY13.3%-8.2%
TTM5.2%5Y14.2%-9.0%
5Y14.2%10Y15.5%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%-200.1%+205.3%
TTM5.2%-216.8%+222.0%
YOY13.3%-288.3%+301.6%
5Y14.2%-449.1%+463.3%
10Y15.5%-605.5%+621.0%
1.1.2. Return on Assets

Shows how efficient Wuhan Hvsen Biotechnology Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • 1.8% Return on Assets means that Wuhan Hvsen Biotechnology Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.8%0.0%
TTM1.8%YOY4.8%-3.1%
TTM1.8%5Y8.2%-6.4%
5Y8.2%10Y11.1%-2.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-13.3%+15.1%
TTM1.8%-12.8%+14.6%
YOY4.8%-11.7%+16.5%
5Y8.2%-13.9%+22.1%
10Y11.1%-15.7%+26.8%
1.1.3. Return on Equity

Shows how efficient Wuhan Hvsen Biotechnology Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • 3.4% Return on Equity means Wuhan Hvsen Biotechnology Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.4%0.0%
TTM3.4%YOY8.2%-4.8%
TTM3.4%5Y12.5%-9.1%
5Y12.5%10Y17.1%-4.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%-16.9%+20.3%
TTM3.4%-16.1%+19.5%
YOY8.2%-15.1%+23.3%
5Y12.5%-19.3%+31.8%
10Y17.1%-20.2%+37.3%

1.2. Operating Efficiency of Wuhan Hvsen Biotechnology Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Wuhan Hvsen Biotechnology Co Ltd is operating .

  • Measures how much profit Wuhan Hvsen Biotechnology Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 6.0% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 6.0%. The company is operating less efficient.
  • The TTM is 6.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.0%TTM6.0%0.0%
TTM6.0%YOY13.6%-7.6%
TTM6.0%5Y15.2%-9.2%
5Y15.2%10Y16.9%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%-296.2%+302.2%
TTM6.0%-232.5%+238.5%
YOY13.6%-298.2%+311.8%
5Y15.2%-492.1%+507.3%
10Y16.9%-632.4%+649.3%
1.2.2. Operating Ratio

Measures how efficient Wuhan Hvsen Biotechnology Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.70 means that the operating costs are ¥1.70 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 1.702. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.702. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.702TTM1.7020.000
TTM1.702YOY1.592+0.111
TTM1.7025Y1.491+0.211
5Y1.49110Y1.447+0.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7023.231-1.529
TTM1.7023.310-1.608
YOY1.5923.890-2.298
5Y1.4915.739-4.248
10Y1.4477.876-6.429

1.3. Liquidity of Wuhan Hvsen Biotechnology Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Wuhan Hvsen Biotechnology Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.68 means the company has ¥1.68 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 1.679. The company is able to pay all its short-term debts. +1
  • The TTM is 1.679. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.679TTM1.6790.000
TTM1.679YOY3.177-1.498
TTM1.6795Y2.350-0.671
5Y2.35010Y2.210+0.141
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6793.890-2.211
TTM1.6794.173-2.494
YOY3.1775.344-2.167
5Y2.3506.126-3.776
10Y2.2106.448-4.238
1.3.2. Quick Ratio

Measures if Wuhan Hvsen Biotechnology Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.87 means the company can pay off ¥0.87 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 0.869. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.869. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.869TTM0.8690.000
TTM0.869YOY0.576+0.294
TTM0.8695Y0.784+0.085
5Y0.78410Y0.716+0.068
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8693.514-2.645
TTM0.8693.998-3.129
YOY0.5765.380-4.804
5Y0.7846.105-5.321
10Y0.7166.404-5.688

1.4. Solvency of Wuhan Hvsen Biotechnology Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Wuhan Hvsen Biotechnology Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.48 means that Wuhan Hvsen Biotechnology Co Ltd assets are financed with 48.4% credit (debt) and the remaining percentage (100% - 48.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 0.484. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.484. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.484TTM0.4840.000
TTM0.484YOY0.410+0.075
TTM0.4845Y0.366+0.118
5Y0.36610Y0.364+0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4840.339+0.145
TTM0.4840.336+0.148
YOY0.4100.271+0.139
5Y0.3660.3660.000
10Y0.3640.389-0.025
1.4.2. Debt to Equity Ratio

Measures if Wuhan Hvsen Biotechnology Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 93.9% means that company has ¥0.94 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The MRQ is 0.939. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.939. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.939TTM0.9390.000
TTM0.939YOY0.694+0.246
TTM0.9395Y0.612+0.327
5Y0.61210Y0.600+0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9390.388+0.551
TTM0.9390.402+0.537
YOY0.6940.335+0.359
5Y0.6120.426+0.186
10Y0.6000.461+0.139

2. Market Valuation of Wuhan Hvsen Biotechnology Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Wuhan Hvsen Biotechnology Co Ltd generates.

  • Above 15 is considered overpriced but always compare Wuhan Hvsen Biotechnology Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 64.27 means the investor is paying ¥64.27 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The EOD is 44.895. Based on the earnings, the company is overpriced. -1
  • The MRQ is 64.271. Based on the earnings, the company is expensive. -2
  • The TTM is 64.271. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD44.895MRQ64.271-19.376
MRQ64.271TTM64.2710.000
TTM64.271YOY35.636+28.636
TTM64.2715Y28.804+35.467
5Y28.80410Y24.003+4.801
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD44.895-2.264+47.159
MRQ64.271-2.629+66.900
TTM64.271-2.680+66.951
YOY35.636-4.145+39.781
5Y28.804-6.257+35.061
10Y24.003-6.254+30.257
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The EOD is -7.123. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.198. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.198. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.123MRQ-10.198+3.074
MRQ-10.198TTM-10.1980.000
TTM-10.198YOY-10.654+0.457
TTM-10.1985Y-11.430+1.232
5Y-11.43010Y-9.525-1.905
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.123-2.973-4.150
MRQ-10.198-3.333-6.865
TTM-10.198-3.553-6.645
YOY-10.654-5.605-5.049
5Y-11.430-8.376-3.054
10Y-9.525-8.865-0.660
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Wuhan Hvsen Biotechnology Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.20 means the investor is paying ¥2.20 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Wuhan Hvsen Biotechnology Co Ltd:

  • The EOD is 1.535. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.198. Based on the equity, the company is underpriced. +1
  • The TTM is 2.198. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.535MRQ2.198-0.663
MRQ2.198TTM2.1980.000
TTM2.198YOY2.925-0.727
TTM2.1985Y1.985+0.213
5Y1.98510Y1.654+0.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5351.896-0.361
MRQ2.1982.115+0.083
TTM2.1982.093+0.105
YOY2.9252.884+0.041
5Y1.9853.542-1.557
10Y1.6543.916-2.262
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Wuhan Hvsen Biotechnology Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.455-0.4550%1.424-132%1.588-129%1.547-129%
Book Value Per Share--9.2839.2830%9.738-5%6.314+47%5.486+69%
Current Ratio--1.6791.6790%3.177-47%2.350-29%2.210-24%
Debt To Asset Ratio--0.4840.4840%0.410+18%0.366+32%0.364+33%
Debt To Equity Ratio--0.9390.9390%0.694+35%0.612+53%0.600+56%
Dividend Per Share--0.3760.3760%0.288+31%0.186+102%0.180+109%
Eps--0.3170.3170%0.799-60%0.573-45%0.567-44%
Free Cash Flow Per Share---2.000-2.0000%-2.673+34%-1.192-40%-0.969-52%
Free Cash Flow To Equity Per Share---2.209-2.2090%1.598-238%0.707-412%0.589-475%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---29.412--------
Intrinsic Value_10Y_min---37.489--------
Intrinsic Value_1Y_max---1.574--------
Intrinsic Value_1Y_min---2.411--------
Intrinsic Value_3Y_max---5.776--------
Intrinsic Value_3Y_min---8.452--------
Intrinsic Value_5Y_max---11.239--------
Intrinsic Value_5Y_min---15.772--------
Market Cap2363889864.000-43%3387512595.6003387512595.6000%4734758048.960-28%2949227774.800+15%2457689812.333+38%
Net Profit Margin--0.0520.0520%0.133-61%0.142-64%0.155-67%
Operating Margin--0.0600.0600%0.136-56%0.152-61%0.169-65%
Operating Ratio--1.7021.7020%1.592+7%1.491+14%1.447+18%
Pb Ratio1.535-43%2.1982.1980%2.925-25%1.985+11%1.654+33%
Pe Ratio44.895-43%64.27164.2710%35.636+80%28.804+123%24.003+168%
Price Per Share14.250-43%20.40020.4000%28.480-28%17.762+15%14.802+38%
Price To Free Cash Flow Ratio-7.123+30%-10.198-10.1980%-10.654+4%-11.430+12%-9.525-7%
Price To Total Gains Ratio-181.349+30%-259.615-259.6150%16.635-1661%-78.801-70%-78.801-70%
Quick Ratio--0.8690.8690%0.576+51%0.784+11%0.716+21%
Return On Assets--0.0180.0180%0.048-64%0.082-79%0.111-84%
Return On Equity--0.0340.0340%0.082-58%0.125-73%0.171-80%
Total Gains Per Share---0.079-0.0790%1.712-105%1.774-104%1.727-105%
Usd Book Value--212871789.705212871789.7050%223563707.784-5%144790468.230+47%125794053.927+69%
Usd Book Value Change Per Share---0.063-0.0630%0.197-132%0.219-129%0.214-129%
Usd Book Value Per Share--1.2821.2820%1.345-5%0.872+47%0.758+69%
Usd Dividend Per Share--0.0520.0520%0.040+31%0.026+102%0.025+109%
Usd Eps--0.0440.0440%0.110-60%0.079-45%0.078-44%
Usd Free Cash Flow---45874727.951-45874727.9510%-61372196.547+34%-27339937.319-40%-22227225.066-52%
Usd Free Cash Flow Per Share---0.276-0.2760%-0.369+34%-0.165-40%-0.134-52%
Usd Free Cash Flow To Equity Per Share---0.305-0.3050%0.221-238%0.098-412%0.081-475%
Usd Market Cap326453190.218-43%467815489.452467815489.4520%653870086.561-28%407288355.700+15%339406963.083+38%
Usd Price Per Share1.968-43%2.8172.8170%3.933-28%2.453+15%2.044+38%
Usd Profit--7278764.2647278764.2640%18348730.276-60%13144248.764-45%12988772.922-44%
Usd Revenue--141262599.422141262599.4220%137577542.512+3%100693336.792+40%93111242.353+52%
Usd Total Gains Per Share---0.011-0.0110%0.236-105%0.245-104%0.238-105%
 EOD+4 -4MRQTTM+0 -0YOY+9 -265Y+10 -2510Y+11 -24

3.2. Fundamental Score

Let's check the fundamental score of Wuhan Hvsen Biotechnology Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.895
Price to Book Ratio (EOD)Between0-11.535
Net Profit Margin (MRQ)Greater than00.052
Operating Margin (MRQ)Greater than00.060
Quick Ratio (MRQ)Greater than10.869
Current Ratio (MRQ)Greater than11.679
Debt to Asset Ratio (MRQ)Less than10.484
Debt to Equity Ratio (MRQ)Less than10.939
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.018
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Wuhan Hvsen Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.445
Ma 20Greater thanMa 5013.717
Ma 50Greater thanMa 10011.601
Ma 100Greater thanMa 20012.783
OpenGreater thanClose14.160
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,989,114
Total Liabilities1,447,682
Total Stockholder Equity1,541,432
 As reported
Total Liabilities 1,447,682
Total Stockholder Equity+ 1,541,432
Total Assets = 2,989,114

Assets

Total Assets2,989,114
Total Current Assets1,351,475
Long-term Assets1,637,639
Total Current Assets
Cash And Cash Equivalents 424,044
Short-term Investments 361,677
Net Receivables 337,989
Inventory 199,006
Other Current Assets 8,618
Total Current Assets  (as reported)1,351,475
Total Current Assets  (calculated)1,331,336
+/- 20,140
Long-term Assets
Property Plant Equipment 1,498,079
Intangible Assets 106,874
Other Assets 32,687
Long-term Assets  (as reported)1,637,639
Long-term Assets  (calculated)1,637,639
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities804,925
Long-term Liabilities642,757
Total Stockholder Equity1,541,432
Total Current Liabilities
Short Long Term Debt 220,085
Accounts payable 489,703
Other Current Liabilities 61,463
Total Current Liabilities  (as reported)804,925
Total Current Liabilities  (calculated)771,252
+/- 33,674
Long-term Liabilities
Long term Debt 570,360
Other Liabilities 72,397
Long-term Liabilities Other 1,690
Deferred Long Term Liability 372
Long-term Liabilities  (as reported)642,757
Long-term Liabilities  (calculated)644,818
+/- 2,062
Total Stockholder Equity
Common Stock166,055
Retained Earnings 427,110
Other Stockholders Equity 126,916
Total Stockholder Equity (as reported)1,541,432
Total Stockholder Equity (calculated)720,081
+/- 821,351
Other
Capital Stock166,055
Common Stock Shares Outstanding 166,055
Net Debt 366,401
Net Invested Capital 2,331,877
Net Tangible Assets 1,434,559
Net Working Capital 546,550
Property Plant and Equipment Gross 1,652,666



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
0
344,175
466,596
650,081
1,752,226
2,741,662
2,989,114
2,989,1142,741,6621,752,226650,081466,596344,1750
   > Total Current Assets 
136,583
177,700
275,751
292,543
1,177,152
1,598,882
1,351,475
1,351,4751,598,8821,177,152292,543275,751177,700136,583
       Cash And Cash Equivalents 
0
53,444
99,455
104,456
345,343
1,068,234
424,044
424,0441,068,234345,343104,45699,45553,4440
       Short-term Investments 
0
0
0
0
240,633
30,216
361,677
361,67730,216240,6330000
       Net Receivables 
28,894
44,529
89,328
106,962
201,657
259,464
337,989
337,989259,464201,657106,96289,32844,52928,894
       Inventory 
47,962
57,903
82,280
72,416
127,268
231,551
199,006
199,006231,551127,26872,41682,28057,90347,962
       Other Current Assets 
7,448
21,780
4,679
8,709
24,986
9,417
8,618
8,6189,41724,9868,7094,67921,7807,448
   > Long-term Assets 
0
166,476
190,844
357,538
575,074
1,142,780
1,637,639
1,637,6391,142,780575,074357,538190,844166,4760
       Property Plant Equipment 
88,346
98,451
114,365
233,306
412,329
1,006,798
1,498,079
1,498,0791,006,798412,329233,306114,36598,45188,346
       Intangible Assets 
0
65,071
63,583
98,189
95,771
110,059
106,874
106,874110,05995,77198,18963,58365,0710
       Long-term Assets Other 
0
743
9,558
15,518
56,715
15,463
7,543
7,54315,46356,71515,5189,5587430
> Total Liabilities 
0
121,062
142,081
271,799
373,076
1,122,808
1,447,682
1,447,6821,122,808373,076271,799142,081121,0620
   > Total Current Liabilities 
97,914
118,081
138,924
203,767
338,672
503,269
804,925
804,925503,269338,672203,767138,924118,08197,914
       Short Long Term Debt 
0
0
25,000
29,000
63,000
100,000
220,085
220,085100,00063,00029,00025,00000
       Accounts payable 
48,735
44,102
70,446
121,050
194,437
311,330
489,703
489,703311,330194,437121,05070,44644,10248,735
       Other Current Liabilities 
21,015
36,989
20,535
22,161
44,981
57,931
61,463
61,46357,93144,98122,16120,53536,98921,015
   > Long-term Liabilities 
0
2,981
3,157
68,032
34,404
619,539
642,757
642,757619,53934,40468,0323,1572,9810
       Long-term Liabilities Other 
0
750
750
750
3,285
2,895
1,690
1,6902,8953,2857507507500
       Deferred Long Term Liability 
494
1,255
318
0
0
0
372
3720003181,255494
> Total Stockholder Equity
0
223,114
324,515
378,281
1,379,150
1,618,854
1,541,432
1,541,4321,618,8541,379,150378,281324,515223,1140
   Retained Earnings 
18,077
86,432
137,834
191,600
341,756
429,314
427,110
427,110429,314341,756191,600137,83486,43218,077
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,042,808
Cost of Revenue-808,138
Gross Profit234,670234,670
 
Operating Income (+$)
Gross Profit234,670
Operating Expense-976,579
Operating Income66,230-741,908
 
Operating Expense (+$)
Research Development45,455
Selling General Administrative78,522
Selling And Marketing Expenses-
Operating Expense976,579123,977
 
Net Interest Income (+$)
Interest Income5,506
Interest Expense-22,146
Other Finance Cost-1,817
Net Interest Income-18,457
 
Pretax Income (+$)
Operating Income66,230
Net Interest Income-18,457
Other Non-Operating Income Expenses-
Income Before Tax (EBT)42,89066,230
EBIT - interestExpense = -22,146
41,178
63,324
Interest Expense22,146
Earnings Before Interest and Taxes (EBIT)-65,036
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax42,890
Tax Provision-1,712
Net Income From Continuing Ops41,17841,178
Net Income41,178
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-18,457
 

Technical Analysis of Wuhan Hvsen Biotechnology Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Wuhan Hvsen Biotechnology Co Ltd. The general trend of Wuhan Hvsen Biotechnology Co Ltd is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Wuhan Hvsen Biotechnology Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Wuhan Hvsen Biotechnology Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 16.49 < 16.67 < 17.44.

The bearish price targets are: 11.65 > 11.45 > 9.64.

Tweet this
Wuhan Hvsen Biotechnology Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Wuhan Hvsen Biotechnology Co Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Wuhan Hvsen Biotechnology Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Wuhan Hvsen Biotechnology Co Ltd. The current macd is 0.48081085.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Wuhan Hvsen Biotechnology Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Wuhan Hvsen Biotechnology Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Wuhan Hvsen Biotechnology Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Wuhan Hvsen Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWuhan Hvsen Biotechnology Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Wuhan Hvsen Biotechnology Co Ltd. The current adx is 32.51.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Wuhan Hvsen Biotechnology Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Wuhan Hvsen Biotechnology Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Wuhan Hvsen Biotechnology Co Ltd. The current sar is 15.53.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Wuhan Hvsen Biotechnology Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Wuhan Hvsen Biotechnology Co Ltd. The current rsi is 57.45. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Wuhan Hvsen Biotechnology Co Ltd Daily Relative Strength Index (RSI) ChartWuhan Hvsen Biotechnology Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Wuhan Hvsen Biotechnology Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Wuhan Hvsen Biotechnology Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Wuhan Hvsen Biotechnology Co Ltd Daily Stochastic Oscillator ChartWuhan Hvsen Biotechnology Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Wuhan Hvsen Biotechnology Co Ltd. The current cci is 39.32.

Wuhan Hvsen Biotechnology Co Ltd Daily Commodity Channel Index (CCI) ChartWuhan Hvsen Biotechnology Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Wuhan Hvsen Biotechnology Co Ltd. The current cmo is 15.35.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Wuhan Hvsen Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) ChartWuhan Hvsen Biotechnology Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Wuhan Hvsen Biotechnology Co Ltd. The current willr is -46.28099174.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Wuhan Hvsen Biotechnology Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Wuhan Hvsen Biotechnology Co Ltd Daily Williams %R ChartWuhan Hvsen Biotechnology Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Wuhan Hvsen Biotechnology Co Ltd.

Wuhan Hvsen Biotechnology Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Wuhan Hvsen Biotechnology Co Ltd. The current atr is 1.02939349.

Wuhan Hvsen Biotechnology Co Ltd Daily Average True Range (ATR) ChartWuhan Hvsen Biotechnology Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Wuhan Hvsen Biotechnology Co Ltd. The current obv is 28,327,605.

Wuhan Hvsen Biotechnology Co Ltd Daily On-Balance Volume (OBV) ChartWuhan Hvsen Biotechnology Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Wuhan Hvsen Biotechnology Co Ltd. The current mfi is 57.22.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Wuhan Hvsen Biotechnology Co Ltd Daily Money Flow Index (MFI) ChartWuhan Hvsen Biotechnology Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Wuhan Hvsen Biotechnology Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Wuhan Hvsen Biotechnology Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Wuhan Hvsen Biotechnology Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.445
Ma 20Greater thanMa 5013.717
Ma 50Greater thanMa 10011.601
Ma 100Greater thanMa 20012.783
OpenGreater thanClose14.160
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Wuhan Hvsen Biotechnology Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Wuhan Hvsen Biotechnology Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Wuhan Hvsen Biotechnology Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Wuhan Hvsen Biotechnology Co Ltd

I send you an email if I find something interesting about Wuhan Hvsen Biotechnology Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Wuhan Hvsen Biotechnology Co Ltd.

Receive notifications about Wuhan Hvsen Biotechnology Co Ltd in your mailbox!